A study published in the British Journal of Pharmacology on 3 March, led by University of Queensland researchers Associate Professor Trent Woodruff and Dr John Lee, has found the drug “PMX205” extends the life of mice that have a SOD1 mutation, when administered before or during very early disease onset. More studies are now underway to determine the safety of PMX205 before it can be tested in humans. 'Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis' tttp://onlinelibrary.wiley.com/doi/10.1111/bph.13730/full
Postive results for PMX205 in mice with SOD1 mutation
Latest News

Thank you Ash and Holly
Earlier this month, Ashley Rice and Holly Foenander took on the Deadly Dozen at the Hunter Sports Centre, raising $1,500 to support families faci...

MND NSW Closure during the holiday period
MND NSW offices and InfoLine will be closed for the holiday period from 12pm on Thursday 24 December 2026 and reopen on Monday 4 January 2027. Phones...

Keeping Families Together This Christmas - MND NSW Christmas Appeal 2026
This Christmas, while many gather to celebrate, families affected by MND know that their time together is especially precious. Every moment, and...

Christmas for MND Carers: Expectation versus Reality
For many people, Christmas is a special time of year spent with family and friends. It is a time for celebrating, sharing gifts, enjoying food, taking...
“We can't do this alone. But together, we're unstoppable.”